Request Demo
Last update 08 May 2025
18F-MNI-792
Last update 08 May 2025
Overview
Basic Info
Drug Type Chemical drugs, Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Action inhibitors |
Mechanism CH24H inhibitors(Cholesterol 24-hydroxylase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with 18F-MNI-792NCT02497235
An Open-Label, Positron Emission Tomography, Phase 1 Study With [18F]MNI-792 to Determine Cholesterol 24S-Hydroxylase Target Occupancy of TAK-935 After Single-Dose Oral Administration in Healthy Subjects.
100 Clinical Results associated with 18F-MNI-792
Login to view more data
100 Translational Medicine associated with 18F-MNI-792
Login to view more data
100 Patents (Medical) associated with 18F-MNI-792
Login to view more data
100 Deals associated with 18F-MNI-792
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Nervous System Diseases | Phase 1 | - | - | |
| Epilepsy | Discovery | United States | 01 Jul 2015 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1 | 11 | (TAK-935 600 mg) | tggusdyvbp(fpiayshdys) = lgclehpnqa ovoodvnjld (tkcmfcjynt, qrpthgrkcd - gnngtgzecx) View more | - | 11 Apr 2017 | ||
(TAK-935 50 mg) | ezhszlmsex(rihlvudash) = dqblyoutml kakcwjbzqz (fyzavggvxp, xlqgacsbbz - kbbmvzghue) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free